Characterization of lncRNA Profiles of Plasma-Derived Exosomes From Type 1 Diabetes Mellitus
Copyright © 2022 Pang, Fan, Shi, Li, Wang, Luo, Lin, Huang, Li, Xie and Zhou..
Backgrounds: Exosomes contain several types of transcripts, including long non-coding RNAs (lncRNAs), and have been shown to exert important effects in human diseases. However, the roles of exosomal lncRNAs in type 1 diabetes mellitus (T1DM) have not been well investigated. In the present study, we characterized the plasma-derived exosomal lncRNAs expression profiles of T1DM and predict their potential function in the pathogenesis of T1DM.
Material and Methods: Exosomal lncRNA expression profiles were detected by Illumina Hiseq platform (T1DM subjects N=10; age-, sex- matched Control subjects N=10). Six exosomal lncRNAs were selected to validate their expression level by using quantitative real-time PCR (qRT-PCR) (T1DM subjects N=30; age-, sex- matched Control subjects N=30). Bioinformatics analysis approaches were carried out to explore the potential biological function of differentially expressed lncRNAs.
Results: A total of 162 differentially expressed exosomal lncRNAs were identified in T1DM patients compared with control subjects, among which 77 up-regulated and 85 down-regulated. The expression level of the selected six lncRNAs didn't show significant difference in the following qRT-PCR analysis. Gene Ontology analysis enriched terms such as activation of phospholipase D activity, neuronal cell body membrane, and calcium sensitive guanylate cyclase activator activity for cis-acting genes of lncRNAs, and metal ion binding for trans-acting genes. The most enriched Kyoto Encyclopedia of Genes and Genomes pathways for the lncRNAs were associated with oxidative phosphorylation and Parkinson's disease for cis-acting genes, and pathways in cancer as well as focal adhesion for trans-acting genes.
Conclusions: This study characterized the lncRNA profiles of plasma-derived exosomes from T1DM for the first time and these results highlighted the potential role of exosomal lncRNAs in T1DM pathogenesis. A better understanding of exosomal lncRNA profiling will provide novel insights into its molecular mechanisms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Frontiers in endocrinology - 13(2022) vom: 16., Seite 822221 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pang, Haipeng [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bioinformatics analysis |
---|
Anmerkungen: |
Date Completed 02.06.2022 Date Revised 16.07.2022 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.3389/fendo.2022.822221 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341567787 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341567787 | ||
003 | DE-627 | ||
005 | 20231226012059.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fendo.2022.822221 |2 doi | |
028 | 5 | 2 | |a pubmed24n1138.xml |
035 | |a (DE-627)NLM341567787 | ||
035 | |a (NLM)35634499 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pang, Haipeng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Characterization of lncRNA Profiles of Plasma-Derived Exosomes From Type 1 Diabetes Mellitus |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.06.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Pang, Fan, Shi, Li, Wang, Luo, Lin, Huang, Li, Xie and Zhou. | ||
520 | |a Backgrounds: Exosomes contain several types of transcripts, including long non-coding RNAs (lncRNAs), and have been shown to exert important effects in human diseases. However, the roles of exosomal lncRNAs in type 1 diabetes mellitus (T1DM) have not been well investigated. In the present study, we characterized the plasma-derived exosomal lncRNAs expression profiles of T1DM and predict their potential function in the pathogenesis of T1DM | ||
520 | |a Material and Methods: Exosomal lncRNA expression profiles were detected by Illumina Hiseq platform (T1DM subjects N=10; age-, sex- matched Control subjects N=10). Six exosomal lncRNAs were selected to validate their expression level by using quantitative real-time PCR (qRT-PCR) (T1DM subjects N=30; age-, sex- matched Control subjects N=30). Bioinformatics analysis approaches were carried out to explore the potential biological function of differentially expressed lncRNAs | ||
520 | |a Results: A total of 162 differentially expressed exosomal lncRNAs were identified in T1DM patients compared with control subjects, among which 77 up-regulated and 85 down-regulated. The expression level of the selected six lncRNAs didn't show significant difference in the following qRT-PCR analysis. Gene Ontology analysis enriched terms such as activation of phospholipase D activity, neuronal cell body membrane, and calcium sensitive guanylate cyclase activator activity for cis-acting genes of lncRNAs, and metal ion binding for trans-acting genes. The most enriched Kyoto Encyclopedia of Genes and Genomes pathways for the lncRNAs were associated with oxidative phosphorylation and Parkinson's disease for cis-acting genes, and pathways in cancer as well as focal adhesion for trans-acting genes | ||
520 | |a Conclusions: This study characterized the lncRNA profiles of plasma-derived exosomes from T1DM for the first time and these results highlighted the potential role of exosomal lncRNAs in T1DM pathogenesis. A better understanding of exosomal lncRNA profiling will provide novel insights into its molecular mechanisms | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a bioinformatics analysis | |
650 | 4 | |a exosomes | |
650 | 4 | |a long non-coding RNA | |
650 | 4 | |a plasma-derived | |
650 | 4 | |a type 1 diabetes mellitus | |
650 | 7 | |a RNA, Long Noncoding |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
700 | 1 | |a Fan, Wenqi |e verfasserin |4 aut | |
700 | 1 | |a Shi, Xiajie |e verfasserin |4 aut | |
700 | 1 | |a Li, Jiaqi |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yimeng |e verfasserin |4 aut | |
700 | 1 | |a Luo, Shuoming |e verfasserin |4 aut | |
700 | 1 | |a Lin, Jian |e verfasserin |4 aut | |
700 | 1 | |a Huang, Gan |e verfasserin |4 aut | |
700 | 1 | |a Li, Xia |e verfasserin |4 aut | |
700 | 1 | |a Xie, Zhiguo |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Zhiguang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in endocrinology |d 2010 |g 13(2022) vom: 16., Seite 822221 |w (DE-627)NLM208813357 |x 1664-2392 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g day:16 |g pages:822221 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fendo.2022.822221 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |b 16 |h 822221 |